Levels of High-Density Lipoprotein Cholesterol are Associated With Biomarkers of Inflammation in Patients With Acute

Héctor González-Pacheco1, Luis M Amezcua-Guerra2, Armando Vazquez-Rangel3

  • 1Coronary Care Unit, National Institute of Cardiology, Mexico City, Mexico.

Insights

In acute coronary syndrome (ACS) patients, very low high-density lipoprotein cholesterol (HDL-C) is linked to higher inflammation markers like hs-CRP and lower albumin. These inflammatory markers independently predict very low HDL-C levels in ACS.

Area of Science:

  • Cardiology
  • Clinical Biochemistry
  • Inflammation Research

Background:

  • Inflammation is inversely correlated with high-density lipoprotein cholesterol (HDL-C) in various pathologic conditions.
  • Understanding this relationship in acute coronary syndrome (ACS) is crucial for risk stratification and management.

Purpose of the Study:

  • To investigate the association between very low HDL-C levels and inflammatory biomarkers in patients with ACS.
  • To identify independent predictors of very low HDL-C levels in this patient population.

Main Methods:

  • A cross-sectional study involving 6,134 patients diagnosed with ACS.
  • Patients were categorized based on HDL-C levels: very low (<30 mg/dl), low (30-39.9 mg/dl), and normal (≥40 mg/dl).
  • Serum levels of high-sensitivity C-reactive protein (hs-CRP), albumin, and white blood cell count were analyzed at admission.

Main Results:

  • 18.5% of ACS patients presented with very low HDL-C levels.
  • Patients with very low HDL-C exhibited significantly higher hs-CRP and lower albumin levels compared to those with low or normal HDL-C.
  • Low serum albumin (≤3.5 g/dl) and elevated hs-CRP (≥10 mg/L) were identified as independent predictors of very low HDL-C.

Conclusions:

  • Very low HDL-C levels in ACS patients are independently associated with elevated hs-CRP and reduced serum albumin.
  • These findings highlight the interplay between lipid metabolism and inflammation in ACS.
  • The study suggests potential for using inflammatory markers to identify ACS patients at risk for very low HDL-C.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
754
Inflammation01:38

Inflammation

Overview
64.4K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
440
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
727
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K